Session Details

Poster session 1: Lipids
26 Aug 11:00 - 16:00 Miscellaneous Poster Session Posters - Poster Area
Learning Objectives: Posters are on display from 11:00 - 16:00. Presenters will be by their poster during the lunch break from 12:30 and 13:30 for posters viewing time

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
11:00P627Associations between very low concentrations of LDL-cholesterol and health outcomes in the reasons for geographical and racial differences in stroke (REGARDS) StudyPeter PENSON (Liverpool, United Kingdom)
11:00P628Cholesterol efflux capacity and incident atherosclerotic cardiovascular disease events in a Japanese general populationMasatsune OGURA (Suita, Japan)
11:00P629Undertreatment of female patients in lipid-lowering for secondary prevention in Europe, Canada, South-Africa, Middle East and China: results of the dyslipidemia international study (dysis)Anselm Kai GITT (Ludwigshafen, Germany)
11:00P630Comparison of plaque microstructures between two high-intensity statin therapies: rosuvastatin versus atorvastatinSatoshi HONDA (Adelaide, Australia)
11:00P631Sex-related differences in clinical characteristics, low-density lipoprotein cholesterol control and cardiovascular outcomes in familial hypercholesterolemia.Takahito DOI (Suita, Japan)
11:00P632Relationship of outpatient provider volume and lipid screening performance measure adherence among patients at risk of cardiovascular diseaseJacob UDELL (Toronto, Canada)
11:00P633The association between LDL-C reduction and new events of diabetes and AMI during PCSK9 inhibitor treatment: A meta-analysisChristian LEWINTER (Copenhagen, Denmark)
11:00P634Association of high intensity statin with lower mortality in Asian patients with acute myocardial infarctionPo-Sheng CHEN (Tainan, Taiwan ROC)
11:00P636Risk of misclassification with a non-fasting lipid profile in secondary cardiovascular prevention Boudewijn KLOP (Rotterdam, Netherlands)
11:00P637Anacetrapib decreases LDL-C in patients with heterozygous familial hypercholesterolemia irrespective of the underlying genetic mutationYale MITCHEL (Rahway, United States of America)
11:00P638Potential candidates for PCSK9 inhibitors among patients with stable coronary artery disease presumed to be on maximally tolerated hypolipidemic treatmentLoukianos RALLIDIS (Argiroupolis, Greece)
11:00P639Triglyceride associated with cholesterol crystallization of atheroma in patients with coronary artery disease who received a statin: optical coherence tomographic analysisShunsuke USAMI (Suita City, Japan)
11:00P640On-treatment lipid profiles to predict the cardiovascular outcomes in patients with chronic kidney disease without dialysis--outcome results from the multi-center T-SPARCLE registry studyLi-Ting HO (Taipei, Taiwan ROC)
11:00P641Lipoprotein (a) and premature myocardial infarction Loukianos RALLIDIS (Argiroupolis, Greece)